Ampio Pharmaceuticals.
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Ampio Pharmaceuticals. sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).
Ampio Pharmaceuticals.: 12 sponsored US clinical trials, none currently recruiting.
Ampio Pharmaceuticals. sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 5 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoarthritis of the Hand, with 1 trials.
Top-decile sponsor footprint
Ampio Pharmaceuticals. ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
12 total, page 1 of 1
A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)
NCT04880161
Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen
NCT04839965
A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19
NCT04868890
Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress
NCT04606784
Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation
NCT04456452
Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.
NCT03988023
Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee
NCT03349645
AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee
NCT03182686
AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint
NCT02762760
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
NCT02556710
A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis
NCT02242435
A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain
NCT02184156
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 2 |
| Phase 3 | 5 |
Therapeutic Areas
How the Ampio Pharmaceuticals. archive is shaped
12 indexed studies, none listed as recruiting (0% open); 8 completed (67%).
Phase mix: 5 late (III/IV) vs 7 early (I/II) (balanced across stages).
Top condition: Osteoarthritis of the Hand (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Ampio Pharmaceuticals.: archived-pipeline peers nationwide
Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Ampio Pharmaceuticals. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 12 archived trials
- Alachua Government Services · 12 trials · 0% recruiting
- Allergy Therapeutics · 12 trials · 0% recruiting
- Angiodynamics · 12 trials · 17% recruiting
- Apnimed · 12 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Ampio Pharmaceuticals. page
12 registered trials is a research-attention snapshot, not an endorsement of Ampio Pharmaceuticals. or any single study.
- None of Ampio Pharmaceuticals.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Osteoarthritis of the Hand is the condition Ampio Pharmaceuticals. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoarthritis of the Hand trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ampio Pharmaceuticals. pipeline card: 12 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.